Literature DB >> 16533484

Management of hypertension in the setting of autonomic dysfunction.

Cyndya Shibao1, Alfredo Gamboa, André Diedrich, Italo Biaggioni.   

Abstract

Supine hypertension is a common finding in patients with autonomic failure; it is associated with end-organ damage and produces nighttime pressure diuresis with worsening of orthostatic hypotension. During the daytime, it is best treated by avoiding the supine posture. At night, simple measures such as raising the head of the bed by 6 to 9 inches can be effective, but most patients require pharmacologic treatment. Transdermal nitroglycerin (0.1 to 0.2 mg/h) or nifedipine (30 mg, orally) has proved to be effective. Hydralazine and minoxidil are usually less effective but may be useful in a given patient. One key therapeutic concept is the hypersensitivity of these patients to depressor agents, requiring a careful titration of the doses on an individual basis. For those patients with proven residual sympathetic tone, as in multiple system atrophy, central sympatholytics such as clonidine may provide an alternative.

Entities:  

Year:  2006        PMID: 16533484     DOI: 10.1007/s11936-006-0002-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  16 in total

1.  Hypertensive cardiovascular damage in patients with primary autonomic failure.

Authors:  T D Vagaonescu; D Saadia; S Tuhrim; R A Phillips; H Kaufmann
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

2.  Blood pressure in autonomic failure: drinks, meals and other ordeals.

Authors:  J R Shannon; J Jordan; D Robertson
Journal:  Clin Sci (Lond)       Date:  1998-01       Impact factor: 6.124

Review 3.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

4.  Sympathetically mediated hypertension in autonomic failure.

Authors:  J R Shannon; J Jordan; A Diedrich; B Pohar; B K Black; D Robertson; I Biaggioni
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

5.  Water drinking as a treatment for orthostatic syndromes.

Authors:  John R Shannon; Andre Diedrich; Italo Biaggioni; Jens Tank; Rose Marie Robertson; David Robertson; Jens Jordan
Journal:  Am J Med       Date:  2002-04-01       Impact factor: 4.965

Review 6.  Treatment of orthostatic hypotension.

Authors:  Roy Freeman
Journal:  Semin Neurol       Date:  2003-12       Impact factor: 3.420

7.  Mineralocorticoid induced hypertension and noradrenaline spillover in man.

Authors:  M Pirpiris; H Cox; M Esler; G L Jennings; J A Whitworth
Journal:  Clin Exp Hypertens       Date:  1994-03       Impact factor: 1.749

8.  The hypertension of autonomic failure and its treatment.

Authors:  J Shannon; J Jordan; F Costa; R M Robertson; I Biaggioni
Journal:  Hypertension       Date:  1997-11       Impact factor: 10.190

Review 9.  Hypertension in orthostatic hypotension and autonomic dysfunction.

Authors:  Italo Biaggioni; Rose Marie Robertson
Journal:  Cardiol Clin       Date:  2002-05       Impact factor: 2.213

10.  The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade.

Authors:  André Diedrich; Jens Jordan; Jens Tank; John R Shannon; Rosemarie Robertson; Friedrich C Luft; David Robertson; Italo Biaggioni
Journal:  J Hypertens       Date:  2003-09       Impact factor: 4.844

View more
  6 in total

1.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

Review 2.  The Pharmacology of Autonomic Failure: From Hypotension to Hypertension.

Authors:  Italo Biaggioni
Journal:  Pharmacol Rev       Date:  2017-01       Impact factor: 25.468

Review 3.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Gerd Fuchs; Wolfgang Greulich; Heinz Reichmann; Michael Schwarz; Birgit Herting
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

4.  Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.

Authors:  Yehonatan Sharabi; David S Goldstein
Journal:  J Neurol Sci       Date:  2011-07-16       Impact factor: 3.181

5.  Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure.

Authors:  Gregory D Fink
Journal:  Hypertension       Date:  2008-12-29       Impact factor: 10.190

Review 6.  Management of Orthostatic Hypotension in Parkinson's Disease.

Authors:  Alessandra Fanciulli; Fabian Leys; Cristian Falup-Pecurariu; Roland Thijs; Gregor K Wenning
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.